CMPS

Compass Pathways plc is a leading mental health care company dedicated to innovating treatments for mental health conditions through the development of psychedelic therapies, particularly psilocybin. Based in Cheshire, UK, and active in both the UK and US markets, the company is at the forefront of clinical research aimed at addressing significant unmet needs in mental health care, notably for treatment-resistant depression. With a robust commitment to research and development, Compass Pathways is poised to redefine the standards of mental health treatment, contributing to the advancement of therapeutic options that promise to enhance patient outcomes on a global scale.